| 000 | 01700 a2200409 4500 | ||
|---|---|---|---|
| 005 | 20250514051910.0 | ||
| 264 | 0 | _c20030307 | |
| 008 | 200303s 0 0 eng d | ||
| 022 | _a1055-9965 | ||
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aWali, Ramesh K | |
| 245 | 0 | 0 |
_aUrsodeoxycholic acid inhibits the initiation and postinitiation phases of azoxymethane-induced colonic tumor development. _h[electronic resource] |
| 260 |
_bCancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology _cNov 2002 |
||
| 300 |
_a1316-21 p. _bdigital |
||
| 500 | _aPublication Type: Comparative Study; Journal Article; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, P.H.S. | ||
| 650 | 0 | 4 | _aAnimals |
| 650 | 0 | 4 | _aAzoxymethane |
| 650 | 0 | 4 |
_aCholagogues and Choleretics _xtherapeutic use |
| 650 | 0 | 4 |
_aColonic Neoplasms _xchemically induced |
| 650 | 0 | 4 | _aDisease Models, Animal |
| 650 | 0 | 4 | _aDisease Progression |
| 650 | 0 | 4 | _aDose-Response Relationship, Drug |
| 650 | 0 | 4 | _aIncidence |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aRats |
| 650 | 0 | 4 | _aRats, Inbred F344 |
| 650 | 0 | 4 | _aTime Factors |
| 650 | 0 | 4 | _aTreatment Outcome |
| 650 | 0 | 4 |
_aUrsodeoxycholic Acid _xtherapeutic use |
| 700 | 1 | _aStoiber, Debra | |
| 700 | 1 | _aNguyen, Lan | |
| 700 | 1 | _aHart, John | |
| 700 | 1 | _aSitrin, Michael D | |
| 700 | 1 | _aBrasitus, Thomas | |
| 700 | 1 | _aBissonnette, Marc | |
| 773 | 0 |
_tCancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology _gvol. 11 _gno. 11 _gp. 1316-21 |
|
| 999 |
_c12240672 _d12240672 |
||